SCHEMBL28032286

SCHEMBL28032286

CC(C)C1N=CC=CN1c1ccccc1

nearest known ligand 0.30

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
CASP1 P29466 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27727248 0.77 MAOA (0.33) MEN1KMT2ANPSR1
SCHEMBL20658953 0.73 SMN1; SMN2 (0.31) NPSR1
SCHEMBL28023706 0.73 MAPT (0.30) NPSR1
SCHEMBL28024161 0.73 MAPT (0.30) NPSR1
SCHEMBL27945472 0.73 MAPT (0.30) NPSR1
SCHEMBL28031694 0.72 MEN1 (0.30) MEN1KMT2A
SCHEMBL28031660 0.69 ALDH1A1 (0.33)
SCHEMBL29349092 0.67
SCHEMBL28032265 0.67 MEN1 (0.31) MEN1KMT2A
SCHEMBL28023719 0.66 FADS1 (0.38) MEN1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104837490-B Pyrimido [4, 5-b ] quinoline-4, 5(3H, 10H) -diones as nonsense mutation suppressors 诺华股份有限公司 2017-10-03 CN claimed
CN-104837490-A Pyrimido [4,5-b ] quinoline-4, 5(3H,10H) -diones as nonsense mutation suppressors NOVARTIS AG 2015-08-12 CN claimed
CN-107569487-A Pyrimido [4,5 b] quinoline 4,5 (3H, 10H) diketone as nonsense mutation repressor 诺华股份有限公司 2018-01-12 CN disclosed
CN-104837490-B Pyrimido [4, 5-b ] quinoline-4, 5(3H, 10H) -diones as nonsense mutation suppressors 诺华股份有限公司 2017-10-03 CN disclosed
CN-104837490-A Pyrimido [4,5-b ] quinoline-4, 5(3H,10H) -diones as nonsense mutation suppressors NOVARTIS AG 2015-08-12 CN disclosed